Pacific Biosciences Of California Net Profit Margin 2010-2024 | PACB

Pacific Biosciences Of California net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Pacific Biosciences Of California Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-03-31 $0.20B $-0.30B -147.76%
2023-12-31 $0.20B $-0.31B -152.74%
2023-09-30 $0.17B $-0.31B -181.76%
2023-06-30 $0.15B $-0.32B -218.49%
2023-03-31 $0.13B $-0.32B -240.60%
2022-12-31 $0.13B $-0.31B -246.46%
2022-09-30 $0.14B $-0.30B -219.12%
2022-06-30 $0.14B $-0.20B -146.76%
2022-03-31 $0.14B $-0.17B -128.89%
2021-12-31 $0.13B $-0.18B -137.40%
2021-09-30 $0.12B $-0.04B -29.51%
2021-06-30 $0.11B $-0.08B -72.64%
2021-03-31 $0.09B $-0.06B -64.13%
2020-12-31 $0.08B $0.03B 36.71%
2020-09-30 $0.08B $-0.05B -57.50%
2020-06-30 $0.08B $-0.05B -61.45%
2020-03-31 $0.09B $-0.05B -58.24%
2019-12-31 $0.09B $-0.08B -92.31%
2019-09-30 $0.08B $-0.12B -138.55%
2019-06-30 $0.08B $-0.11B -140.51%
2019-03-31 $0.08B $-0.11B -143.42%
2018-12-31 $0.08B $-0.10B -130.38%
2018-09-30 $0.08B $-0.09B -110.71%
2018-06-30 $0.09B $-0.09B -100.00%
2018-03-31 $0.09B $-0.09B -105.68%
2017-12-31 $0.09B $-0.09B -98.94%
2017-09-30 $0.10B $-0.09B -95.79%
2017-06-30 $0.10B $-0.09B -89.58%
2017-03-31 $0.10B $-0.08B -80.41%
2016-12-31 $0.09B $-0.07B -80.22%
2016-09-30 $0.10B $-0.06B -54.46%
2016-06-30 $0.09B $-0.04B -40.00%
2016-03-31 $0.09B $-0.03B -31.91%
2015-12-31 $0.09B $-0.03B -33.33%
2015-09-30 $0.07B $-0.05B -66.22%
2015-06-30 $0.08B $-0.06B -74.07%
2015-03-31 $0.07B $-0.07B -100.00%
2014-12-31 $0.06B $-0.07B -108.20%
2014-09-30 $0.05B $-0.06B -120.75%
2014-06-30 $0.04B $-0.08B -192.31%
2014-03-31 $0.03B $-0.08B -223.53%
2013-12-31 $0.03B $-0.08B -278.57%
2013-09-30 $0.03B $-0.08B -332.00%
2013-06-30 $0.02B $-0.09B -409.52%
2013-03-31 $0.02B $-0.09B -400.00%
2012-12-31 $0.03B $-0.10B -365.38%
2012-09-30 $0.03B $-0.10B -300.00%
2012-06-30 $0.04B $-0.10B -255.00%
2012-03-31 $0.04B $-0.10B -231.82%
2011-12-31 $0.03B $-0.11B -320.59%
2011-09-30 $0.02B $-0.12B -554.55%
2011-06-30 $0.01B $-0.13B -1218.18%
2011-03-31 $0.00B $-0.15B -14500.00%
2010-12-31 $0.00B $-0.14B -7000.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.479B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.361B 26.46
Intuitive Surgical (ISRG) United States $151.024B 90.98
Edwards Lifesciences (EW) United States $52.601B 34.23
DexCom (DXCM) United States $46.111B 69.85
Alcon (ALC) Switzerland $44.714B 32.04
IDEXX Laboratories (IDXX) United States $41.624B 48.79
IQVIA Holdings (IQV) United States $38.763B 22.49
STERIS (STE) Ireland $21.579B 25.21
SONOVA HOLDING (SONVY) Switzerland $18.556B 0.00
Waters (WAT) United States $17.496B 25.71
Hologic (HOLX) United States $16.754B 18.74
Fresenius Medical Care AG KGaA (FMS) Germany $12.100B 14.12
Sysmex ADR (SSMXY) Japan $9.900B 31.05
Teleflex (TFX) United States $9.811B 15.27
Globus Medical (GMED) United States $8.882B 26.04
Penumbra (PEN) United States $7.279B 82.72
Masimo (MASI) United States $7.203B 41.49
Glaukos (GKOS) United States $5.671B 0.00
TransMedics (TMDX) United States $4.677B 443.78
Integer Holdings (ITGR) United States $3.897B 23.55
PROCEPT BioRobotics (PRCT) United States $3.248B 0.00
Tandem Diabetes Care (TNDM) United States $2.928B 0.00
LivaNova (LIVN) United Kingdom $2.853B 16.94
Inari Medical (NARI) United States $2.634B 0.00
Nihon Kohden (NHNKY) Japan $2.601B 13.78
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.305B 10.05
RxSight (RXST) United States $2.141B 0.00
Veracyte (VCYT) United States $1.603B 0.00
Alphatec Holdings (ATEC) United States $1.491B 0.00
Artivion (AORT) United States $0.964B 92.48
AVANOS MEDICAL, INC (AVNS) United States $0.883B 17.18
OPKO Health (OPK) United States $0.871B 0.00
Silk Road Medical (SILK) United States $0.844B 0.00
OrthoPediatrics (KIDS) United States $0.698B 0.00
Pulse Biosciences (PLSE) United States $0.664B 0.00
IRadimed (IRMD) United States $0.548B 30.67
SiBone (SIBN) United States $0.522B 0.00
Paragon 28 (FNA) United States $0.510B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.66
ORTHOFIX MEDICAL INC (OFIX) United States $0.465B 0.00
Treace Medical Concepts (TMCI) United States $0.375B 0.00
AxoGen (AXGN) United States $0.334B 0.00
Nevro (NVRO) United States $0.332B 0.00
Sight Sciences (SGHT) United States $0.326B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.58
Semler Scientific (SMLR) United States $0.271B 13.73
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.220B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
908 Devices (MASS) United States $0.200B 0.00
EDAP TMS S.A (EDAP) France $0.200B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Inogen (INGN) United States $0.172B 0.00
Accuray (ARAY) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.151B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Yubo Biotech (YBGJ) China $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
ReWalk Robotics (LFWD) Israel $0.039B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.026B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00